Narjust Florez: Improve health disparities in real-world precision oncology
Narjust Florez, Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center, shared a post on X:
“Great discussion by Dr. Kenneth Kehl about the use of AI in oncology to improve health disparities in real-world precision oncology. Wonderful discussion.”
Narjust Florez is the Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer. In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023